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Peripheral venous catheterization is a common technique in hospitals which is not always successful, result-
ing in multiple punctures and degradation of the vessels. This scenario, which we have termed ‘difficult
peripheral venous access’, is associated to delays in care, obtention of samples or diagnosis, as well as a
higher use of central catheters.
This study intends to identify risk factors associated to the incidence of ‘difficult peripheral venous access’ in
adults at hospital.
We designed a systematic review of published studies (protocol PROSPERO 2018 CRD42018089160). We
conducted structured electronic searches using key words and specific vocabulary, as well as directed
searches in several databases. After validity analysis, we selected 7 studies with observational methodology.
We found great variability in the definition of ‘difficult peripheral venous access’ and in the variables pro-
posed as risk factors. Statistically significant factors through studies include demographic and anthropomet-
ric variables (gender, Body Mass Index), as well as medical and health conditions (diabetes, renal
insufficiency, parenteral drug abuse, cancer chemotherapy), together with variables related to the vein or
vascular access (vein visibility and palpability, vessel diameter, previous history of difficulty). Some studies
have also considered variables related to the professional performing the technique.
Meta-analyses were carried out for gender and obesity as potential risk factors. Only obesity appeared as a
statistically significant risk factor with OR of 1.48; 95% CI (1.03 to 1.93; p = 0.016). Methodological heteroge-
neity prevented the development of further meta-analyses.
It is essential to design future studies with diverse hospital populations, in which a wide selection of poten-
tial risk factors can be studied in a unique analysis. Our work identifies the most relevant variables that
should be included in those studies.
© 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)Key Words:
Peripheral venous catheterization
Risk factors
Cannulationand review, and agreed with
iguez@hmanacor.org
selection and data extraction.
s.
Inc. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)Introduction
Peripheral intravenous catheters (PIVC) are the most common
invasive devices used during clinical care worldwide. At present
about 60% of hospital inpatients would have a PIVC inserted,1,2 and
up to 90% of patients attending the emergency department (ED)
would require a PIVC at any time during care.3 Almost 70% of these
patients experience catheter-related complications, mainly infection,
phlebitis, occlusion, dislodgement, infiltration and extravasation, that
274 M.A. Rodríguez-Calero et al. / Heart & Lung 49 (2020) 273286lead to extended hospital stay and costs and increase the risk of vas-
cular damage and bloodstream infections.2,47
Despite its ubiquity and frequency, cannulation may be often diffi-
cult or even not possible. This situation is frequently referred to as
‘difficult intravenous access’ (DIVA),8,9 although there is not a consen-
sus or a generally accepted definition. In addition, the term ‘difficult
peripheral intravenous cannulation’ (DPIVC)10 has been suggested to
differentiate peripheral from central catheterization. DPIVC causes
pain and distress to patients,11 can lead to adverse events including
diagnostic delays12 and result in catheter-related complications such
as infiltration, vein collapse or nerve damage.1315 In addition, DPIVC
can also be challenging or stressful for health professionals involved
in intravenous therapy.16 DPIVC occurs in 1024% of adult patients17
and up to 37% in children requiring a cannula.18 Previous evidence
indicates that PIVC inserted with difficulty remain in situ for less
time, with a higher number of catheter-related adverse events,
mainly infiltration, phlebitis and occlusion.1921 In these circumstan-
ces, the replacement with a new vascular device might be necessary.
In fact, DPIVC leads to the need for multiple punctures and frequent
catheter replacements,22 eventually resulting in a progressive vascu-
lar degradation which would hinder future cannulation attempts.23
This scenario has been referred to as 'vascular exhaustion', and is
mainly seen in people living with chronic diseases experiencing
repeated hospital admissions or admitted for prolonged periods of
time.24 These patients are likely to require the insertion of central
lines not because of a therapeutic indication but rather due to diffi-
culties securing a peripheral device.23 Central venous catheters bring
higher insertion and maintenance-related complications that could
be avoided if an early identification of DPIVC cases could be
achieved.25 Furthermore, DPIVC is associated with a higher use of
advanced canalization techniques, mainly ultrasound and near-
infrared2628 leading to increased procedure time and costs.
Early identification of DPIVC is an emerging field of research
worldwide. A recent scoping review by Carr et al29 explored scales
and clinical prediction rules designed to improve peripheral cannula-
tion success. Despite the high heterogeneity of the studies included,
this review identified a variety of tools for the early detection and
prevention of DPIVC.
In this respect, several variables and conditions have been pro-
posed as potential risk factors for DPIVC. A narrative review pub-
lished in 2010 by Sabri et al.17 presented up to 50 variables
potentially associated with ‘failed attempts’ of cannulation such as
age, gender, skin characteristics, weight, vein characteristics and sev-
eral health conditions. However, the included studies were very het-
erogeneous and of diverse quality. Thus, we found it important to
carry out this systematic review rigorously examining the risk factors
associated with DPIVC.
To recognize potential risk factors for DPIVC and eventually high-
risk situations or patients, can be useful in clinical practice to identify
difficulty and prevent from the consequences of multiple punctures,
guiding to the optimal selection of an intra venous device at the
beginning of hospital admission.
Objective
This study aims to identify and analyse the different risk factors
associated with DPIVC in adults during hospital care. In addition, we
aim to describe the definition of DPIVC among studies.
Review question
What are the risk factors associated with difficult peripheral
venous access cannulation during hospital care to adult patients in
need of peripheral cannulation for intravenous therapy? How is dif-
ficult peripheral venous access cannulation defined in published
studies?METHODS
Systematic review of published studies following a protocol reg-
istered in an international prospective register of systematic
reviews (PROSPERO 2018 CRD42018089160).30 The present article
intends to respond to the first of the objectives proposed in the
mentioned protocol. The present report also aligns with the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement for publication and report of systematic
reviews31 (Supplementary file 1).
Searches
We conducted structured searches of published studies using spe-
cific subject headings or vocabulary, as well as free terms or key
words in order to increase sensitivity.
The search terms were combined with the Boolean operators OR
and AND. Searches were limited to Humans, as well as Adults or +18
years when available. Terms such as pediatrics or arterial catheteriza-
tionwere combined with ‘NOT’ to ensure accuracy of the results. Sup-
plementary file 2 offers a full description of search terms including
those used to exclude not relevant inputs as well as a description of
the search strategy used along databases.
The search strategy was piloted in May 2018 in a single data-
base to ensure sensitivity and specificity. An expert librarian from
the University of the Balearic Islands was consulted in this phase.
Final searches were developed by the first author on July 2018 and
then reproduced by a second researcher to ensure the validity of
the results.
The electronic searches were conducted in PubMed, MEDLINE
and CINHAL (via Ovid), Embase, CINAHL, Cochrane Library, Web of
Science (WOS), Scopus (via WOS) and Medes (journals in Spanish).
The main clinical trial registries, including Cochrane Central Regis-
ter of Controlled Trials, Clinicaltrials.gov (USA) and EU clinical tri-
als register (Europe), were reviewed. We also examined titles from
relevant journals on the field of vascular access, namely Journal of
Vascular Access (JVA) and the Journal of the Association for Vascu-
lar Access (JAVA). In addition, references cited by included studies
and previous reviews were screened to detect other potentially rel-
evant studies. Searches were limited to English, Spanish and Portu-
guese, and to the last 15 years (2003 to 2018), in coincidence with
the first publications about this matter.
Types of study included
Inclusion criteria was set a priori to select the type of designs with
which risk factors can be specifically addressed. We considered
cohort, case-control and cross-sectional studies defining and analy-
sing DPIVC or procedure success, and the associated factors. Experi-
mental studies were not excluded initially.
Systematic reviews, cost analysis or economic evaluations were
not to be considered for inclusion. However, bibliographies of these
reports were examined to search for potentially relevant studies.
Context
This review focuses on peripheral cannulation during hospital care,
which includes any hospital area or setting where patients are hospi-
talized or continually attended. Extra-hospital emergency or primary
care settings were considered beyond the scope of this review.
Participants/population
Patients older than 18 years in need of peripheral cannulation for
intravenous therapy during hospital assistance.
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Fig. 1. Study selection flow diagram.
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We considered a potential risk factor any previous variable or
condition present in the patient or in the context, which could be sig-
nificantly associated with DPIVC.Comparator/control
Patients without the proposed risk factors undergoing peripheral
cannulation in hospitals. Studies without a comparator were also
considered for their inclusion.Primary outcome(s)
Incidence of DPIVC, as defined by authors.
Cannulation success rate (defined as the rate of attempts that
results in a effective cannulation for fluid infusion) or first attempt
success rate (defined as the rate of successful cannulation achieved at
the first attempt).
Number of punctures or attempts to cannulation.
Vein visualization or detection rates, as measured by authors.Data extraction
After electronic searches, studies were selected by title in every
database and included in a reference manager. Duplicates were
removed, and abstracts were then revised to select only primary
research. Remaining reports were included in full-text revision. We
examined study aims to ensure the review objective was included. In
case of multiple publications of data from the same study, only the
first report was considered for inclusion. Data was extracted inde-
pendently by the first author using and contrasted with the review
team. We used ReviewManager 5 and ad hoc forms in this phase. Dis-
agreements were resolved by consensus of the 4 reviewers who took
part in this process.Risk of bias assessment
We used the Newcastle-Ottawa validated tool for the evaluation
of internal validity of longitudinal studies (NOS)32 and the adapted
version for cross-sectional studies.33 This tool assigns a score when a
study meets one or several conditions that add validity or methodo-
logical rigor. Additionally, the STROBE statement check list (version
for all observational methods)34 was used to direct critical review.
Table 1
Characteristics of included studies.
FIRST AUTHOR, YEAR COUNTRY SAMPLE SIZE SETTING /POPULATION AIM METHOD PRIMARY OUTCOME
Sebbane 2013 France 563 Emergency Relationship between BMI and
DPIVC in an ED setting.
Patient-related predicting
factors.
Prospective
observational
1st attempt cannulation
failure
Fields 2014 USA 743 Emergency Risk factors for DPIVC in adult
patients presenting to the ED.
Prospective
observational
DPIVC
Carr 2016 Australia 734 Emergency Incidence of first-time insertion
success
Clinician rationale for PIVC use.
Patient and clinician factors
influencing first time success.
Cohort Insertion success
van Loon 2016 The Netherlands 1063 Operation area Risk factors for failure to perform
peripheral intravenous cannula-
tion.
Simplified additive A- DPIVC
scale.
Cross-sectional 1st attempt cannulation
failure
Armenteros-Yeguas
2017
Spain 135 Hospitalized advanced
chronic
Prevalence of DPIVC in complex
patients with multi-morbidity.
Associated risk factors.
Cross-Sectional DPIVC
Piredda 2017 Italy 763 Radiology Risk factors for DPIVC in relation to
characteristics of patients,
healthcare providers and devices
in adult patients accessing radi-
ology service
Prospective
observational
DPIVC
Witting 2017 USA 358 Emergency Variables associated with the need
for advanced techniques.
Estimate delay associated with the
need for advanced techniques.
Case-control Need for advanced tech-
niques for intravenous
access
DPIVC, Difficult peripheral intravenous cannulation; PIVC, Peripheral intra venous catheter; ED, Emergency department; BMI, Body mass index.
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pendently and registered in a review form. Every study was then dis-
cussed in a group of 4 reviewers.
We carried out a descriptive analysis of included studies accord-
ing to the dimensions of the NOS scale, allowing to identify areas in
risk of bias and methodological weaknesses.
Strategy for data synthesis
We first conducted descriptive analysis of published studies,
including date of publication, country, sample size and potential riskTable 2
Characteristics of excluded studies.
FIRST AUTHOR, YEAR COUNTRY SETTING/POPULATION AIM
Jacobson 2005 USA Hospital nurses. Patient and
outpatient settings
Variables contribu
venous catheter
Techniques to facil
Lapostolle 2007 France Pre-hospital emergency
clinicians and patients
Patient, operator a
associated to dif
venous cannulat
Webster 2007 Australia Hospital nurses and
radiographers
Validation of tool f
Witting 2012 USA Emergency nurses and
patients
Association betwee
culty and attenti
de la Torre-Montero, 2014 Spain Oncology outpatients receiv-
ing chemotherapy
Design and validat
assessment scale
Ichimura 2015 Japan Healthy volunteers Association betwee
vein variables
Miliani 2017 France Patients attended at hospital
wards
Incidence of adver
indwell time and
removal
Pagnutti 2015 Italy Oncology outpatients receiv-
ing chemotherapy
Development of to
venous access
Rippey 2016 Australia Emergency nurses and
patients
Clinician likelihood
nulation success
Ehrhardt 2018 USA Hospital nurses and patients Validation of ‘diffic
access’ (DPIVC) t
Feinsmith 2018 USA Emergency nurses Implementation of
cult intravenousfactors. We performed a descriptive synthesis of the definition of
DPIVC used in every study, together with the conditions that allow
classifying a venous access as difficult. Data from relevant studies
was summarized and discussed.
We calculated odds ratios (OR) using the data extracted for every
risk factor described in the included studies.
Meta-analyses were carried out using odds ratio as association
measure, and random effect models with the inverse of variance
method (DerSimonian Laird). Only variables with homogeneous out-
come measurement were considered in this analysis. Observed het-
erogeneity was evaluated by I2, between-study variance by t2.METHOD REASON FOR REJECTION
ting to peripheral
insertion difficulty.
itate cannulation
Cross-sectional Study aim. Population/sample.
nd disease factors
ficult peripheral
ion
Prospective observational Population/sample
or vein classification Prospective observational Study aim. Population/sample
n IV access diffi-
on delays
Cohort Study aim. Population/sample
ion of venous Prospective observational Study aim. Population/sample.
n palpation and Cross-sectional Study aim. Population/sample
se events during the
after catheter
Prospective observational Study aim
ol for difficult intra- Cross-sectional. Validation
study
Study aim. Population/sample
of first-time can-
.
Cohort Extended report of previously
included data.
ult intravenous
ool
Cross-seccional. Validation
study.
Study aim. Population/sample.
program for diffi-
access
Quasi-experimental (pre-
post intervention)
Study aim. Population/sample.
Table 3
Risk of bias of included studies.
FIRST AUTHOR, YEAR Selection Comparability Outcome/exposure
Sebbane 2013 Selected group of users.
Convenience sampling.
Sample size not justified.
Fields 2014 Selected group of users.
Convenience sampling
Carr 2016 Selected group of users.
Convenience sampling
van Loon 2016 Selected group of users.
Convenience sampling
Armenteros-Yeguas 2017 Potential risk factor (history of DPIVC) also
present as selection criteria. Uncontrolled
potential confounders
Unclear or not mentioned origin of data (hos-
pital recordings vs. patient interview)
Piredda 2017 Selected group of users. Uncertain report of expo-
sure assessment (cannulation time)
Doubtful criteria for main variable definition
(DPIVC). Indefinite variables (such as veins
“with many valves”, “fragile”, “hard” or
“tortuous”)
Witting 2017 Uncertain case definition and representativeness.
Uncertain criteria for case selection.
Different 'sets' of controls used indistinctly.
Unexplained criteria for case selection
(absent or present factor/s)
Case and controls obtained by different
methods. Unexplained criteria for different
rate of cases and controls
DPIVC: difficult peripheral intravenous cannulation.
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effects. To estimate possible sources of heterogeneity, sensitivity
analyses were arranged considering the type of outcome used to
evaluate DPIVC, the type of design, and the clinical setting where the
studies were conducted. Finally, a meta-regression was computed for
estimating the influence of risk of bias, different clinical settings, and
the type of design. Residual variation due to heterogeneity was
assessed by residual I2, and the proportion of between study variance
by adjusted R2. Publication bias was assessed by funnel plots.
Post-hoc analyses were carried out to evaluate the optimal infor-
mation size (OIS). This is defined as the minimum amount of informa-
tion required in the collective literature for reliable conclusions about
an intervention to be reached.35 It is calculated estimating if the total
number of patients included in the systematic review is less than the
number of patients generated by a sample size calculation for a single
adequately powered study.36
We used the Review Manager 5 (RevMan 5) software for data
extraction and risk of bias assessment. All the analyses were per-
formed with Stata 14.2 (StataCorp. 2015. Stata Statistical Software:
Release 14. College Station, TX: StataCorp LP).
RESULTS
The electronic searches produced a total of 1597 titles. Other six
additional reports were identified by direct searches in specialized
journals in the field of vascular access or the review of bibliographyTable 4
Definition of cannulation success/difficulty.
FIRST AUTHOR, YEAR 1st attempt SUCCESS DPIVC
Sebbane 2013 79% +1 failed attem
Fields 2014 75.6% +2 failed attem
OR
Need for re
van Loon 2016 82.87% +1 failed attem
Carr 2016 85.69% Not defined
Armenteros-Yeguas 2017 Not measured Previous histo
OR/AND
Not visible or
Piredda 2017 88.9% Procedure las
OR
1st attempt fa
Witting 2017 Not reported Need for rescuof previous studies. After the selection process, seven studies were
selected and included in our review. Study selection process and
rejection causes are described in Fig. 1.
Characteristics of included studies
All selected studies were published after 2012 and conducted in
different European countries,3740 Australia41 and the United
States.42,43 The 7 selected studies circumscribe to specific hospital
areas, 4 of them were carried out in the ED. Table 1 resumes the main
characteristics of these studies.
Main characteristics of excluded studies are described in Table 2.
Risk of bias of included studies
Table 3 shows areas of risk of bias in patient selection, groups
comparability criteria and outcomes assessment. Higher NOS scores
appeared in items related to outcome evaluation and follow-up.
Items related to patient selection revealed methodological weak-
nesses in 6 studies.
Definition of cannulation success/difficulty
The definition of DPIVC used in the different studies was not
homogeneous, and was frequently linked to multiple cannulation
attempts. The minumum number of failed attempts for theOverall DPIVC RATE
pts of cannulation 21%
pts of cannulation
scue vascular access
11.8%
pts of cannulation 17.12%
Not measured
ry of +2 failed attempts of cannulation
palpable veins after tourniquet
59.3%
ting more than 1 min
ilure
39.4%
e vascular access Not reported
Table 5
Risk factors for DPIVC/cannulation success.
DEMOGRAPHIC
FACTORS
ARMENTEROS-
YEGUAS 2017
CARR 2016 FIELDS 2014 PIREDDA 2017 SEBBANE 2013 VAN LOON 2016 WITTING 2017
Age IR 3.04 (1.058.83)
>80 years (b)
0.97 (0.551.91) >64
years
1.17 (0.921.48) >64
years
IR IR
Female gender 2.85 (1.316.25)
Female (b)
1.88 (1.093.25) (a) 0.99 (0.621.56) 1.68 (1.282.21)
Female (b)
IR 0.89 (0.641.22)
VASCULAR ACCESS
CONDITIONS
ARMENTEROS-
YEGUAS 2017
CARR 2016 FIELDS 2014 PIREDDA 2017 SEBBANE 2013 VAN LOON 2016 WITTING 2017
Cannulation site:
antecubital fossa
2.82 (1.286.24) vs fore-
arm (b)
IR
Catheter size 6.4 (3.411.9) 2224 G
vs >20 G (a)
0.74 (0.511.08) 20G IR 5.56 (2.6311.73) 22 G
(a)
Diameter of vein
<2mm
2.97 (1.675.31) (a) 3.37 (2.125.36) (b)
Haematomas/swelling 1.80 (0.8883.658) 2.36 (1.264.40) (a)
History of catheter-
related
complications
2.14 (1.064.33) (a) IR
History of difficult
venous access/res-
cue techniques
2.14 (1.064.33) (a) 16.7 (6.841) (b) 5.05 (3.347.62) (a) 3.86 (2.396.25) (b) 6.1 (3.311.3) (b)
Vein palpability 5.05 (1.3718.64) Not
palpable (b)
0.78 (0.730.83)
Palpable
IR 4.94 (2.858.56) Not
palpable (b)
Vein visibility 4.62 (2.179.86) Not vis-
ible (b)
0.87 (0.830.91)
Visible
IR 3.63 (2.096.32) Not
visible (b)
HEALTH CONDITIONS ARMENTEROS-
YEGUAS 2017
CARR 2016 FIELDS 2014 PIREDDA 2017 SEBBANE 2013 VAN LOON 2016 WITTING 2017
>30 BMI/Obesity 2.15 (0.964.82) 2.29 (0.995.31) 1.42 (0.902.23) 1.70 (1.372.10) (b) 1.98 (1.093.60) (b) 1.03 (1.011.05) (a) 0.63 (0.371.05)
<18.5 BMI/Emaciated 0.07 (0.020.34) Emaci-
ated vs normal
2.24 (1.074.67)
<18.5 BMI (b)
ASA IV 3.87 (1.421054) (a)
Cancer 2.14 (0.895.15) (a) 1.97 (1.32.97) (a)
Chemotherapy 1.29 (0.652.56) (a) 1.69 (1.172.44) (b) 1.21 (0.662.21)
Diabetes 1.26 (0.632.51) 2.1 (1.33.4) (b) 2.41 (1.055.49) (a) 0.95 (0.591.54) 1.6 (1.02.8) (a)
Hypotension/
Hypovolemia
8.15 (3.7517.71) (a) 0.75 (0.321.73)
Osteo-articular
disease
2.56 (1.125.83) (a)
Parenteral drug abuse 0.82 (0.312.12) 2.4 (1.15.3) (b) IR 1.30 (0.592.89) 4.7 (2.99.1) (b)
Renal insuffiency/
Dialysis
1.00 (0.422.36) 0.73 (0.163.21) 1.83 (1.023.26) (a) 1.66 (0.823.8)
Sickle cell disease 3.5 (1.48.4) (b)
Vascular disease 3.90 (0.7320.88) 1.88 (1.352.62) (a)
HEALTHCARE-
RELATED FACTORS
ARMENTEROS-
YEGUAS 2017
CARR 2016 FIELDS 2014 PIREDDA 2017 SEBBANE 2013 VAN LOON 2016 WITTING 2017
>6 h preoperative
fasting
12.62 (7.5421.12) (a)
Admissions in past 90
days
1.75 (1.102.78) (a)
Unplanned surgery 4.86 (2.928.07) (b)
PROFESSIONAL/CLINI-
CIAN FACTORS
ARMENTEROS-
YEGUAS 2017
CARR 2016 FIELDS 2014 PIREDDA 2017 SEBBANE 2013 VAN LOON 2016 WITTING 2017
>100 IV cannulas
inserted
5.5 (1.8616.30) (b)
>800 IV cannulas
inserted
7.64 (2.4823.51) (b)
Perceived likelihood
of success/Per-
ceived difficulty
1.06 (1.041.07) (b) IR IR
Risk factors are represented with Odds Ratios (95% confidence interval).
(a): significant risk factor in univariate analysis; (b): significant risk factor in multivariate analysis (independent risk factors); IR: Insufficient reporting: data provided in primary
study does not allow the proposed analysis. Blank: outcome not measured.
BMI: Body mass Index; ASA: American Society of Anesthesiogists classification; IV: intravenous.
278 M.A. Rodríguez-Calero et al. / Heart & Lung 49 (2020) 273286consideration of DPIVC was variable. Some studies also considered
'cannulation time' and other situations such as a previous history of
difficulty or the need of 'advanced' or 'rescue' techniques (mainly
ultrasound, near-infrared and external jugular puncture). Table 4
synthesizes the different definitions of DPIVC and frequencies, which
varied from 11.8% to 59.3%. First puncture success definition resulted
to be more homogeneous, with rates varying from 75.6% to 88.9%.
Risk factors for cannulation difficulty /success
A full list and description of the results of univariate analysis dis-
played is available in Supplementary file 3.
Statistically significant risk factors associated with cannulation
difficulty or success in at least one study are resumed in Table 5. Thistable intends to work as a guide for the selection of relevant variables
in future studies. Undefined variables, which could not be reproduced
in further studies, were not included in this representation. Variables
without statistical significance in any of the studies were not
expressed in this representation even when they are frequently con-
sidered such as ethnicity or skin color.
Included studies propose demographic variables (age, gender,
ethnicity), anthropometric measures (Body Mass Index), conditions
of the vascular access (vein visibility and palpability, vessel diameter,
a previous history of difficulty), patient’s health conditions, mainly
chronic illnesses or treatments (diabetes, renal insufficiency, paren-
teral drug abuse, cancer chemotherapy), healthcare-related variables
(recent interventions or hospital attention) and clinician-related vari-
ables such as professional expertise.
NOTE: Weights are from random effects analysis
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Fig. 2. Forest-plot for gender as a risk factor for DPIVC or first attempt cannulation failure.
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Gender was analysed in six of the studies, female gender appeared
as an independent risk factor in two of them.37,38 We carried out a
meta-analysis for female gender as a risk factor for DPIVC, obtaining
a final OR of 1.35; 95% CI (1.00 to 1.82; p = 0.056), with a predictive
interval of 0.53 to 3.44, an overall heterogeneity of 57.7%, and an esti-
mate of between-study variance t2 = 0.06 (Fig. 2).
Sensitivity analyses were deployed to estimate the effect of set-
ting (hospital ward, emergency room, or surgical or interventional
procedures room) (Fig. 3), type of study (cross-sectional or longitudi-
nal) (Fig. 4), and type of outcome (DPIVC or failure or first cannulation
attempt) (Fig. 5). Female gender appeared as a significative risk factor
only in the study carried out in hospitalization ward.
Moreover, a meta-regression was calculated using risk of bias, set-
ting, and type of design (longitudinal or cross-sectional) as predictors
of the obtained OR. None of these predictors showed influence in the
results (Table 6). The OIS for this meta-analysis to obtain an odds
ratio of 1.35 was n = 1688, so that the obtained final sample of 4001
was enough.
Vascular access conditions
Variables related to vascular access conditions were included in
all the studies, though heterogeneously assessed, which prevented
the development of meta-analysis. In this group, a previous history
of multiple punctures38,40,42 or a previous use of ‘rescue techni-
ques’42,43 resulted to be significant risk factors in some studies. In
addition, the ability to locate a target vein by visualization (vein
visibility) or palpation (vein palpability) after tourniquet is associ-
ated to technique success and the appearance of DPIVC. The four
studies in which the visibility and palpability conditions of the ves-
sel were evaluated,3841 found statistical significance with up to
5.5 OR (IC 1,3718.64) for not palpable veins observed in the study
by Carr et al.41Health conditions
The most commonly chronic conditions hypothesised as risk fac-
tors for DPIVC were obesity, diabetes, parenteral drug abuse, chemo-
therapy and dialysis. Only one of these studies found statistical
significance for diabetes as an independent risk factor,42 and two
found it for parenteral drug abuse.42,43
Obesity, or high values of Body Mass Index (BMI), was hypothes-
ised as a risk factor for DPIVC in all the included studies. Three of
them found statistical significance.3840 This variable was subject to
meta-analysis and showed a global OR of 1.48; 95%CI (1.03 to 1.93;
p = 0.016), with a predictive interval of 0.23 to 2.73, an overall het-
erogeneity of 64%, and an estimate of between-study variance
t2 = 0.15 (Fig. 6).
Sensitivity analyses adjusted for type of setting (Fig. 7), design
(Fig. 8) and type of outcome (Fig. 9) indicated how obesity obtained
a stronger association in those studies carried out in Emergency,
having a longitudinal design, and using the outcome DPIVC. Meta-
regression presented no effect due to type of study, clinical setting
or risk of bias (Table 5). OIS estimated to obtain an odds ratio of 1.48
was 1012.
Profesional/clinician factors
The study by Carr et al41 showed a strong association between the
previous number of insertions performed by a clinician and the rate
of success of the first attempt of cannulation. The impact of clinician
skills and his/her previous evaluation of the cannulation difficulty
were heterogeneously measured and insufficiently reported for our
analysis.
DISCUSSION
Our review shows that studies to identify and evaluate indepen-
dent risk factors for difficult peripheral venous access are still limited.
NOTE: Weights are from random effects analysis
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Fig. 3. Forest-plot for gender as a risk factor for DPIVC or first attempt cannulation failure adjusted for setting.
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studies included in our review had been published after 2012.
In addition to the small number of suitable studies, these were
highly heterogeneous with regards to the methodology, study popu-
lation, participants’ inclusion criteria and variables analyzed, making
difficult any comparison of findings across studies. Furthermore, the
available studies were circumscribed to specific areas or units, with
different patient profiles and practices. The potential influences of
the environment in which health care is provided cannot be analyzed
with these studies, but it appears to be clear that cannulation practi-
ces can be influenced by differences in users’ health conditions, local
protocols and routines, staff habits and preferences, intended use for
the cannula, and other.44 This fact could explain per se the relevant
differences in DPIVC rates among studies. In this regard, it is conve-
nient to note the high rate of difficulty found by Armenteros et al. in
a sample of complex chronic patients in Spain, with up to 59.3% of
difficult-to-insert catheters.37 Patients in this study are defined by
the concomitance of several chronic illnesses, a high frequentation of
the health system and a documented history of DPIVC in previous
contacts, combining significant conditions that could drive to the pro-
gressive deterioration of the vascular system.
The lack of agreement about the definition of DPIVC among
studies represents another source of heterogeneity that limits com-
parisons. In this sense, the definition selected by Piredda et al38 (ie,
cannulation technique lasting more than 1 min), if applied in clini-
cal practice, would probably result in virtually all cases of cannula-
tion being defined as ‘difficult’. Additionally, it would be necessaryto question how such definition was agreed upon. It would be ben-
eficial to reach an agreement on the operational definition of
DPIVC, accepted by researchers and clinicians, which would ease
the design of homogenous studies and the identification of suscep-
tible patients.
In this respect, first and second puncture success could be easy-to-
manage elements to differentiate DPIVC patients. Some authors have
opted for a definition of more than 2 failed attempts of cannulation
as a trigger to activate the use of advanced techniques including deri-
vation to specialized teams.37,42,45 However, this definition could be
context-dependent, as variables such as the emergency, intended
length of treatment or previous recent catheters could influence first
and successive attempts success. Variables such as a previous history
of DPIVC, availability of visible and/or palpable vessels or previous
failed attempts by other professionals could be also considered in
this definition.
Considering the evidence revised and in the lack of any expert
consensus, we suggest the following definition for DPIVC in order to
facilitate the comparability of future research: We consider a situa-
tion as a DPIVC when it meets at least one of the following condi-
tions: two or more failed puncture attempts; the need for puncture
support techniques (ultrasound, infrared or transillumination) when
accessible vessels cannot be identified by visualization/palpation
(excluding ultrasound scans for other purposes); the need for central
access after failure to achieve peripheral access; decision not to
implement vascular access (no venous access achieved and the proce-
dure is abandoned).
NOTE: Weights are from random effects analysis
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Fig. 4. Forest-plot for gender as a risk factor for DPIVC or first attempt cannulation failure adjusted for type of design.
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Table 6
Meta-regression for gender and obesity as risk factors for DPIVC.
Gender Obesity
B SE p 95% CI B SE p 95% CI
Context 0.32 0.48 0.623 6.43 5.78 0.56 0.56 0.425 2.99 1.86
Risk of bias 1.10 0.52 0.301 7.60 5.57 0.63 0.68 0.447 3.56 2.28
Type of study 0.43 0.51 0.555 6.87 6.02 0.03 0.63 0.964 2.7 2.77
Constant 4.55 2.78 0.350 3.08 3.99 3.95 3.53 0.379 11.25 19.17
Between-study variance: t2 = 0
% residual variation due to heterogeneity: I2 residual = 0.00%.
Proportion of between-study variance explained: Adjusted R2 = 100.00%.
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ture success, which ranges between 75% and 85% across studies. The
development of advanced techniques of cannulation can increase
this rate up to 90%, even in complex situations,8,46 which prevents
from catheter-related complications and premature withdrawal. This
situation would approach the ideal pretention of inserting the mini-
mum number of catheters with the minimum number of punctures
as possible during a hospital process.47,48
Demographic variables are the most commonly considered in the
selected studies. Obesity and extreme values of BMI are frequently
analyzed and controversial.49 Some of the studies found relevant dif-
ferences, especially regarding obesity and high BMI.3841 Our meta-
analysis confirmed this hypothesis, as obesity appears as an indepen-
dent risk factor for DPIVC, possibly associated to complex conditions
of the vascular access, as a higher presence of subcutaneous fat may
influence target vein accesibility.50 Future studies to correlate BMINOTE: Weights are from random effects analysis
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Fig. 6. Forest-plot for obesity as a risk factor forvalues with cannulation attempts would be appropriate to support
this argument.
It also seems to appear a higher risk of DPIVC in women, only
appreciable in 2 studies,37,38 that could not be confirmed in our
meta-analysis. Differences in distribution and thickness of subcutane-
ous fat according to gender have been described, as well as its corre-
lation with BMI, but further studies would be needed to clarify
potential associations with the cannulation technique.51
Regarding the influence of chronic health conditions in DPIVC,
it is believed that a higher frequentation of the health system
would generate a higher use of vascular lines, which would derive
in a progressive fibrosis of the vessel’s walls. The use of vesicant
intravenous infusions during hospital attention is another com-
mon factor potentially affecting this group of population, which
could specially be present in patients receiving IV chemotherapy.52
These two mechanisms (multiple puncture and intravenous.       (0.23, 2.73)
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sive micro-vascular degradation have been described, and associ-
ated to more serious morbidity including vascular disease.53 In the
case of diabetes, micro-vascular alterations secondary to hypergly-
cemia, which are more prevalent in women,54 could be an added
causal mechanism.55
As for the vascular access conditions, a previous history of DPIVC,
as well as vein conditions of visibility and palpability, resulted to be
statistically significant in most of the studies in which they were
included,3841 which constitute a pool of relevant variables that can
be easily applicable in clinical practice to detect patients at risk even
before the first attempt of cannulation.56
Together with these, clinician or professional-related variables
need to be included in future studies and explored with more preci-
sion. Professional expertise in cannulation technique seem to be asso-
ciated, not with a higher success of the technique, but with a more
accurate capacity to predict difficulty based on the assessment of the
vessel previous to puncture.57 These findings, if confirmed, would
reinforce the idea that multiple puncture is an avoidable adverse
event and interventions to avoid it are in our hands.
Early identification of DPIVC patients could facilitate the deriva-
tion to advanced cannulation techniques, vascular access specialized
teams (VAST) or infusion therapy specialists, which could prevent
from the undesirable consequences of multiple punctures andincrease the efficacy of intravenous therapy.58 Although it seems
clear that there are different profiles of patients in risk of DPIVC, the
influence of the environment in which health care is provided is now
a day insufficiently documented. It is necessary to design new inves-
tigations with a wider presence of patients from different areas. This
could provide valuable information to organizations to prioritize
strategies for the attention of patients in risk of DPIVC, such as VASTs,
in areas or units with a higher risk.59
Regarding the limitations of our study, this review focuses in fully
published investigations which excludes brief reports, congress
abstracts and other gray literature. The heterogeneity in the defini-
tions of the studied phenomenon and the limited methodological
quality of some reports must also be considered in the interpretation
of the analysis displayed.
Our study expands the evidence about a wide array of potential
risk factors for DPIVC that can be used to inform the design of future
studies. However, most of the analyzed studies include just a selec-
tion of these variables. In these circumstances, statistical significance
and weight attributed to a certain variable in a single study could be
influenced by other factors, measured or not in the study. Thus, the
possibility of a type 2 error in the included studies must be taken into
account. Future research must consider this situation in sample size
estimation to increase the validity of the results. It becomes necessary
to design wider studies including a broad selection of conditions
M.A. Rodríguez-Calero et al. / Heart & Lung 49 (2020) 273286 285potentially associated to DPIVC. Our review intends to be useful in
this respect, as it allows to delimit relevant variables that must be
considered in future research.
CONCLUSIONS
The present review shows the need to continue exploring DPIVC
with more detail as a health care delivery problem. It also reveals the
need for a consensus in the operational definition of this issue as a
key to allow the comparability of future research.
Our review also presents a broad array of potential risk factors for
DPIVC that should be explored with detail in the future. To clarify the
specific weight of every variable would help patients and profiles at
risk, which would receive routes or protocols for advanced cannula-
tion techniques, to avoid multiple punctures, degradation of vascular
system and associated undesirable effects.
Clinicians responsible for intravenous cannulationmust consider var-
iables such as vessel’s palpability/visibility conditions, previous history of
difficulty and obesity as potential risk factors for DPIVC, and anticipate
alternative solutions different from repeated punctures in order to
increase patient safety and reduce catheter-related complications.
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